Techniques in Regional Anesthesia & Pain Management
Volume 9, Issue 4 , Pages 228-234 , October 2005

Ordering and interpretation of urine toxicology specimens in patients treated with opioids

  • Julie A. Sorensen, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Julie A. Sorensen, MD, Pain Management Center, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756.
    • ,
  • Gilbert J. Fanciullo, MD, MS

References 

  1. Bonica JJ . The role of the anesthesiologist in the management of intractable pain . Can Med Assoc J . 1951;65:103–107
  2. ASAM, Public Policy Statement . “Definitions related to the use of opioids for the treatment of chronic pain” . J Addict Dis . 1998;17:129–130
  3. Savage SR . Opioid therapy of chronic pain (assessment of consequences) . Acta Anaesthesiol Scand . 1999;43:909–917
  4. Centers for Disease Control and Prevention . Increase in poisoning deaths caused by non-illicit drugs–Utah, 1991-2003 . MMWR . 2005;54:33–36
  5. Bendtsen P , Hensing G , Ebeling C , et al.   What are the qualities of dilemmas experienced when prescribing opioids in general practice? . Pain . 1999;82:89–96
  6. Fields HL . In: Pain . New York, NY: McGraw-Hill; 1987;p. P262
  7. Ready LB , Sarkis E , Turner JA . Self-reported versus actual use of medications in chronic pain patients . Pain . 1982;12:285–294
  8. Fishbain DA , Cutler RB , Rosomoff HL , et al.   Validity of self-reported drug use in chronic pain patients . Clin J Pain . 1999;15:184–191
  9. Fishman SM , Papazian JS , Gonzalex S , et al.   Regulating opioid prescribing through prescription monitoring programs (balancing drug diversion and the treatment of pain) . Pain Med . 2004;5:309–324
  10. In: Medical Review Officer’s Handbook . (ed 8). Research Triangle Park, NC, Shults: Quadtrangle Research; 2002;
  11. Dunbar SA , Katz NP . Chronic opioid therapy for non-malignant pain in patients with a history of substance abuse . J Pain Sympt Manage . 1996;11:163–171
  12. Katz NP , Sherburne S , Beach M , et al.   Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy . Anesth Analg . 2003;97:1097–1102
  13. Galloway JH , Marsh ID . Detection of drugs of misuse- an addictive challenge . J Clin Path . 1999;52:713–718
  14. Shults TF . In: Medical Review Officer Handbook . (ed 8). Research Triangle Park, NC: Quadrangle Research; 2002;p. 175–209
  15. Braithwaite RA , Jarvie DR , Minty PS , et al.   Screening for drugs of abuse. I. Opiates, amphetamines, and cocaine . Ann Clin Biochem . 1995;32:123–153
  16. United States Department of Justice Intelligence Brief. National Drug Threat Assessment (http://www.usdoj.gov/ndic/pubs1/1335/1335t.htm#Overview)
  17. Cone EJ , Johnson RE , Darwin WD , et al.   Passive inhalation of marijuana smoke (urinalysis and room air levels of delta-9-tetrohydrocannabinol) . J Anal Toxicol . 1987;11:89–96
  18. Peat MA . Advances in forensic toxicology . Clin Lab Med . 1998;18:263–278
  19. Braithwaite RA , et al.   Screening for drugs of abuse. I. Opiates, amphetamines and cocaine . Ann Clin Biochem . 1995;32:123–153
  20. Zezulak M , Snyder JJ , Needleman SB . Simultaneous analysis of codeine, morphine and heroin after B-glucuronidase hydrolysis . J Forens Sci . 1993;38:1275–1285
  21. Selavka CM . Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results (the Pacific perspective) . J Forens Sci . 1991;36:685–696
  22. Butler SF , Budman SH , Fernandez K , et al.   Validation of a screener and opioid assessment measure for patients with chronic pain . Pain . 2004;112:65–75

PII: S1084-208X(05)00088-1

doi: 10.1053/j.trap.2005.10.009

Techniques in Regional Anesthesia & Pain Management
Volume 9, Issue 4 , Pages 228-234 , October 2005

Article Tools